Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 143 results.
User Information
Export Records
  1. 1.   Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda
  2. Nalwoga, Angela; Roshan, Romin; Moore, Kyle; Marshall, Vickie; Miley, Wendell; Labo, Nazzarena; Nakibuule, Marjorie; Cose, Stephen; Rochford, Rosemary; Newton, Robert; Whitby,Denise
  3. Nature Communications. 2021, Dec 16; 12(1):
  1. 2.   Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge
  2. Om, Kier; Paquin-Proulx, Dominic; Montero, Maria; Peachman, Kristina; Shen, Xiaoying; Wieczorek, Lindsay; Beck, Zoltan; Weiner, Joshua A.; Kim, Dohoon; Li, Yifan; Mdluli, Thembi; Shubin, Zhanna; Bryant, Christopher; Sharma, Vishakha; Tokarev, Andrey; Dawson, Peter; White, Yohann; Appelbe, Oliver; Klatt, Nichole R.; Tovanabutra, Sodsai; Estes, Jacob D.; Matyas, Gary R.; Ferrari, Guido; Alving, Carl R.; Tomaras, Georgia D.; Ackerman, Margaret E.; Michael, Nelson L.; Robb, Merlin L.; Polonis, Victoria; Rolland, Morgane; Eller, Michael A.; Rao, Mangala; Bolton, Diane L.
  3. PLOS PATHOGENS. 2020, SEP; 16(9): pii: e1008764.
  1. 3.   Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques
  2. Virnik, Konstantin; Rosati,Margherita; Medvedev, Alexei; Scanlan, Aaron; Walsh, Gabrielle; Dayton, Frances; Broderick, Kate E; Lewis, Mark; Bryson, Yvonne; Lifson,Jeffrey; Ruprecht, Ruth M; Felber,Barbara; Berkower, Ira
  3. PloS one. 2020, MAR 4; 15(3): e0228163.
  1. 4.   Interleukin 22 disrupts pancreatic function in newborn mice expressing IL-23
  2. Chen, Lili; Strohmeier, Valentina; He, Zhengxiang; Deshpande, Madhura; Catalan-Dibene, Jovani; Durum,Scott; Moran, Thomas M; Kraus, Thomas; Xiong, Huabao; Faith, Jeremiah J; Sodhi, Chhinder P; Hackam, David J; Lira, Sergio A; Furtado, Glaucia C
  3. Nature communications. 2019, Oct 04; 10(1): 4517.
  1. 5.   Vaccine protection against rectal acquisition of SIVmac239 in rhesus macaques
  2. Gonzalez-Nieto, Lucas; Castro, Isabelle M; Bischof, Georg F; Shin, Young C; Ricciardi, Michael J; Bailey, Varian K; Dang, Christine M; Pedreño-Lopez, Nuria; Magnani, Diogo M; Ejima, Keisuke; Allison, David B; Gil, Hwi Min; Evans, David T; Rakasz, Eva G; Lifson,Jeffrey; Desrosiers, Ronald C; Martins, Mauricio A
  3. PLoS pathogens. 2019, Sep 30; 15(9): e1008015.
  1. 6.   Anti-drug Antibody Responses Impair Prophylaxis Mediated by AAV-Delivered HIV-1 Broadly Neutralizing Antibodies
  2. Gardner, Matthew R.; Fetzer, Ina; Kattenhorn, Lisa M.; Davis-Gardner, Meredith E.; Zhou, Amber S.; Alfant, Barnett; Weber, Jesse A.; Kondur, Hema R.; Martinez-Navio, Jose M.; Fuchs, Sebastian P.; Desrosiers, Ronald C.; Gao, Guangping; Lifson,Jeffrey; Farzan, Michael
  3. Molecular therapy : the journal of the American Society of Gene Therapy. 2019, Mar 6; 27(3): 650-660.
  1. 7.   IL-15/IL-15R alpha/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice
  2. Shi, Yimin; Dincheva-Vogel, Lillie; Ayemoba, Charles E.; Fung, Jeffrey P.; Bergamaschi, Cristina; Pavlakis, George; Farzaneh, Farzin; Gaensler, Karin M. L.
  3. BLOOD ADVANCES. 2018, NOV 27; 2(22): 3177-3192.
  1. 8.   Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity
  2. Kumar, Pardeep; Kuhlmann, F. Matthew; Chakraborty, Subhra; Bourgeois, A. Louis; Foulke-Abel, Jennifer; Tumala, Brunda; Vickers, Tim J.; Sack, David A.; DeNearing, Barbara; Harro, Clayton D.; Wright, W. Shea; Gildersleeve, Jeffrey; Ciorba, Matthew A.; Santhanam, Srikanth; Porter, Chad K.; Gutierrez, Ramiro L.; Prouty, Michael G.; Riddle, Mark S.; Polino, Alexander; Sheikh, Alaullah; Donowitz, Mark; Fleckenstein, James M.
  3. JOURNAL OF CLINICAL INVESTIGATION. 2018, Aug 1; 128(8): 3298-3311.
  1. 9.   Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With or Without PF03512676 Adjuvant
  2. La Rosa, C.; Longmate, J.; Lacey, S. F.; Kaltcheva, T.; Sharan, R.; Marsano, D.; Kwon, P.; Drake, J.; Williams, B.; Denison, S.; Broyer, S.; Couture, L.; Nakamura, R.; Kelsey, M. I.; Krieg, A. M.; Diamond, D. J.; Zaia, J. A.
  3. Journal of Infectious Diseases. 2012, Apr; 205(8): 1294-1304.
  1. 10.   Vaccine Protection against Simian Immunodeficiency Virus in Monkeys Using Recombinant Gamma-2 Herpesvirus
  2. Bilello, J. P.; Manrique, J. M.; Shin, Y. C.; Lauer, W.; Li, W. J.; Lifson, J. D.; Mansfield, K. G.; Johnson, R. P.; Desrosiers, R. C.
  3. Journal of Virology. 2011, Dec; 85(23): 12708-12720.
  1. 11.   CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues
  2. Sisirak, V.; Vey, N.; Vanbervliet, B.; Duhen, T.; Puisieux, I.; Homey, B.; Bowman, E. P.; Trinchieri, G.; Dubois, B.; Kaiserlian, D.; Lira, S. A.; Puisieux, A.; Blay, J. Y.; Caux, C.; Bendriss-Vermare, N.
  3. Blood. 2011, Nov; 118(19): 5130-5140.
  1. 12.   Filarial Lymphatic Pathology Reflects Augmented Toll-Like Receptor-Mediated, Mitogen-Activated Protein Kinase-Mediated Proinflammatory Cytokine Production
  2. Babu, S.; Anuradha, R.; Kumar, N. P.; George, P. J.; Kumaraswami, V.; Nutman, T. B.
  3. Infection and Immunity. 2011, Nov; 79(11): 4600-4608.
  1. 13.   Suppressed Type 1, Type 2, and Type 17 Cytokine Responses in Active Tuberculosis in Children
  2. Kumar, N. P.; Anuradha, R.; Suresh, R.; Ganesh, R.; Shankar, J.; Kumaraswami, V.; Nutman, T. B.; Babu, S.
  3. Clinical and Vaccine Immunology. 2011, Nov; 18(11): 1856-1864.
  1. 14.   Highlights of 10 years of immunology in Nature Reviews Immunology
  2. Medzhitov, R.; Shevach, E. M.; Trinchieri, G.; Mellor, A. L.; Munn, D. H.; Gordon, S.; Libby, P.; Hansson, G. K.; Shortman, K.; Dong, C.; Gabrilovich, D.; Gabrysova, L.; Howes, A.; O'Garra, A.
  3. Nature Reviews Immunology. 2011, Oct; 11(10): 693-702.
  1. 15.   One Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide Candidates
  2. Denton, P. W.; Othieno, F.; Martinez-Torres, F.; Zou, W.; Krisko, J. F.; Fleming, E.; Zein, S.; Powell, D. A.; Wahl, A.; Kwak, Y. T.; Welch, B. D.; Kay, M. S.; Payne, D. A.; Gallay, P.; Appella, E.; Estes, J. D.; Lu, M.; Garcia, J. V.
  3. Journal of Virology. 2011, Aug; 85(15): 7582-7593.
  1. 16.   A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial
  2. Ledgerwood, J. E.; Pierson, T. C.; Hubka, S. A.; Desai, N.; Rucker, S.; Gordon, I. J.; Enama, M. E.; Nelson, S.; Nason, M.; Gu, W. J.; Bundrant, N.; Koup, R. A.; Bailer, R. T.; Mascola, J. R.; Nabel, G. J.; Graham, B. S.; Team, V. R. C. S.
  3. Journal of Infectious Diseases. 2011, May; 203(10): 1396-1404.
  1. 17.   Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
  2. Hansen, S. G.; Ford, J. C.; Lewis, M. S.; Ventura, A. B.; Hughes, C. M.; Coyne-Johnson, L.; Whizin, N.; Oswald, K.; Shoemaker, R.; Swanson, T.; Legasse, A. W.; Chiuchiolo, M. J.; Parks, C. L.; Axthelm, M. K.; Nelson, J. A.; Jarvis, M. A.; Piatak, M.; Lifson, J. D.; Picker, L. J.
  3. Nature. 2011, May; 473(7348): 523-U270.
  1. 18.   Factors Associated With Viral Rebound in HIV-1-Infected Individuals Enrolled in a Therapeutic HIV-1 gag Vaccine Trial
  2. Li, J. Z.; Brumme, Z. L.; Brumme, C. J.; Wang, H. Y.; Spritzler, J.; Robertson, M. N.; Lederman, M. M.; Carrington, M.; Walker, B. D.; Schooley, R. T.; Kuritzkes, D. R.; AIDS Clinical Trials Group (ACTG) A5197 Team
  3. Journal of Infectious Diseases. 2011, Apr; 203(7): 976-983.
  1. 19.   FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer
  2. Watkins, S. K.; Zhu, Z. Q.; Riboldi, E.; Shafer-Weaver, K. A.; Stagliano, K. E. R.; Sklavos, M. M.; Ambs, S.; Yagita, H.; Hurwitz, A. A.
  3. Journal of Clinical Investigation. 2011, Apr; 121(4): 1361-1372.
  1. 20.   HIV-1 infected monozygotic twins: a tale of two outcomes
  2. Tazi, L. T. L.; Imamichi, H.; Hirschfeld, S.; Metcalf, J. A.; Orsega, S.; Perez-Losada, M.; Posada, D.; Lane, H. C.; Cr, all
  3. Bmc Evolutionary Biology. 2011, Mar; 11: 9.
  1. 21.   Alterations of T-cell surface markers in older women with persistent human papillomavirus infection
  2. Rodriguez, A. C.; Garcia-Pineres, A. J.; Hildesheim, A.; Herrero, R.; Trivett, M.; Williams, M.; Atmella, I.; Ramirez, M.; Villegas, M.; Schiffman, M.; Burk, R.; Freer, E.; Bonilla, J.; Bratti, C.; Pinto, L. A.
  3. International Journal of Cancer. 2011, Feb; 128(3): 597-607.
  1. 22.   Spontaneous Control of HCV Is Associated With Expression of HLA-B*57 and Preservation of Targeted Epitopes
  2. Kim, A. Y.; Kuntzen, T.; Timm, J.; Nolan, B. E.; Baca, M. A.; Reyor, L. L.; Berical, A. C.; Feller, A. J.; Johnson, K. L.; Zur Wiesch, J. S.; Robbins, G. K.; Chung, R. T.; Walker, B. D.; Carrington, M.; Allen, T. M.; Lauer, G. M.
  3. Gastroenterology. 2011, Feb; 140(2): 686-U434.
  1. 23.   Expression of a Broad Array of Negative Costimulatory Molecules and Blimp-1 in T Cells following Priming by HIV-1 Pulsed Dendritic Cells
  2. Shankar, E. M.; Che, K. F.; Messmer, D.; Lifson, J. D.; Larsson, M.
  3. Molecular Medicine. 2011, Mar-Apr; 17(3-4): 229-240.
  1. 24.   CCL5: A Double-Edged Sword in Host Defense Against the Hepatitis C Virus
  2. Katsounas, A.; Schlaak, J. F.; Lempicki, R. A.
  3. International Reviews of Immunology. 2011, Oct-Dec; 30(5-6): 366-378.
  1. 25.   Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
  2. Shurin, M. R.; Gregory, M.; Morris, J. C.; Malyguine, A. M.
  3. Expert Opinion on Biological Therapy. 2010, Nov; 10(11): 1539-1553.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel